4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
Learn more about:
Related Clinical Trial
Optiflow vs. Convential Anesthesia During Pediatric Laryngeal Papilloma Removal
A Phase I Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
Lenvatinib and Pembrolizumab In HPV-associated RRP
Human Papillomatosis Genotyping of Children in Thailand
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
M7824 in People With Recurrent Respiratory Papillomatosis
INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis
Avelumab for People With Recurrent Respiratory Papillomatosis
4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
Use of Cidofovir for Recurrent Respiratory Papillomatosis